ECH1 and Hepatic steatosis: Previously, ECH1 has been confirmed to mitigate HFD-induced IR and hepatic steatosis directly by restraining the expression of lipogenesis genes and by repressing the insulin pathway via the attenuation of Akt phosphorylation (144).